A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Itraconazole

Specified dose on specified days.

DRUG

Rifampin

Specified dose on specified days

DRUG

Golcadomide

Specified dose on specified days

Trial Locations (2)

Local Institution - 0002, Atlanta

Local Institution - 0001, Lenexa